Arthritis drug 'cuts elderly Covid-19 deaths by two-thirds', say researchers - raising hopes that it will save the most vulnerable
Arthritis drug 'cuts elderly Covid-19 deaths by two-thirds', say researchers - raising hopes that it will save the most vulnerable
Covid patients at 'death's door' recovering with immune system drugs, scientists say
Covid patients at 'death's door' recovering with immune system drugs, scientists say
Baricitinib has Significant Effect on Recovery Time, Most Impactful in COVID-19 Patients Requiring Oxygen
Baricitinib has Significant Effect on Recovery Time, Most Impactful in COVID-19 Patients Requiring Oxygen
BioMed Central Ltd publishes an open access summary of the PROLIFIC protocol
BioMed Central Ltd publishes an open access summary of the PROLIFIC protocol
BioMed Central Ltd publishes an open access summary of the TACTIC-E protocol
BioMed Central Ltd publishes an open access summary of the TACTIC-E protocol
BioMed Central Ltd publishes an open access summary of the TACTIC-R protocol
BioMed Central Ltd publishes an open access summary of the TACTIC-R protocol
COVID and me: A series of seven short dramas about people’s experiences of COVID-19 research
COVID and me: A series of seven short dramas about people’s experiences of COVID-19 research
Quay Expertise Supports New Drug for TACTIC-E COVID-19 Trial
Quay Expertise Supports New Drug for TACTIC-E COVID-19 Trial
Evelo Biosciences Announces EDP1815 to Advance into Phase 2/3 TACTIC-E COVID-19 Trial
Evelo Biosciences Announces EDP1815 to Advance into Phase 2/3 TACTIC-E COVID-19 Trial
TACTIC-E trial to test whether a simple microbe could be an effective treatment for COVID-19
TACTIC-E trial to test whether a simple microbe could be an effective treatment for COVID-19
Cambridge launches fast-turnaround experimental drug trial to treat Covid-19
Cambridge launches fast-turnaround experimental drug trial to treat Covid-19
CUH group launches experimental drug trial to treat Covid-19
CUH group launches experimental drug trial to treat Covid-19
Cambridge launches fast-turnaround experimental drug trial to treat Covid-19
Cambridge launches fast-turnaround experimental drug trial to treat Covid-19
National trial launched, re-purposing drugs to treat COVID-19 patients
National trial launched, re-purposing drugs to treat COVID-19 patients
New national trial launched to find COVID-19 treatment
New national trial launched to find COVID-19 treatment
New trial to prevent organ failure and death in COVID-19 patients launched
New trial to prevent organ failure and death in COVID-19 patients launched
NIHR Cambridge Biomedical Research Centre feature
NIHR Cambridge Biomedical Research Centre feature
National trial launched to find Covid-19 treatment
National trial launched to find Covid-19 treatment
Trial launched testing existing drugs in bid to treat coronavirus patients
Trial launched testing existing drugs in bid to treat coronavirus patients
Research from Cambridge to Combat COVID-19
Research from Cambridge to Combat COVID-19